Form 4 holding
Director
Lexaria Bioscience Corp.
- Security class
- common shares
- Shares / value
- 281,912
- Estimated value
- $202,976
- Report date
- 17 Mar 2026
- Price
- $0.7200
- Ownership
- Private Holding Company
Christopher Bunka - Director at Lexaria Bioscience Corp.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- LEXX on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Christopher Bunka since 16 Aug 2025
Reported holdings for Christopher Bunka in Lexaria Bioscience Corp.
Form 4 holding
Director
Lexaria Bioscience Corp.
- Security class
- common shares
- Shares / value
- 273,543
- Estimated value
- $196,950
- Report date
- 17 Mar 2026
- Price
- $0.7200
- Ownership
- Direct
Form 4 holding
Director
Lexaria Bioscience Corp.
- Security class
- Stock Options
- Shares / value
- 184,834
- Estimated value
- $133,080
- Report date
- 17 Mar 2026
- Price
- $0.7200
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 184,834
Transaction history for Christopher Bunka in Lexaria Bioscience Corp.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.